Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis

NCT06389786 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06389786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06389786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2024
Completion date
May 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate carcinoma, oligometastatic prostate carcinoma, stage i prostate cancer ajcc v8, stage ii prostate cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iva prostate cancer ajcc v8